Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-30.6%

₹20.13

vs ₹29.02 price

Levered DCF

-₹7.14

After debt service

Piotroski score

4 / 9

Average

Altman Z-score

—

Rating

C-

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	15.08×	124.68×	154.77×	121.76×	134.07×	86.64×	10.14×	23.33×
P/B	1.95×	3.72×	6.03×	3.89×	5.57×	6.64×	0.82×	0.83×
P/S	1.48×	2.09×	2.74×	2.24×	4.19×	3×	0.41×	0.49×
EV / EBITDA	11.18×	60.83×	82.62×	53.66×	63.48×	44.67×	6.59×	11.46×
Gross margin	3.7%	6.3%	6.3%	8.5%	12.8%	9.3%	7.5%	13.6%
Operating margin	1.3%	1.4%	1.0%	2.5%	4.0%	3.3%	4.8%	2.8%
Net margin	9.8%	1.7%	1.8%	1.9%	3.1%	3.5%	4.1%	2.1%
Current ratio	1.73×	1.34×	1.35×	1.63×	6.23×	1.4×	1.17×	1.32×
Debt / equity	0.14×	0.03×	0.02×	0.03×	0.03×	0.03×	0.08×	0.12×
Interest coverage	37.37×	12.68×	10.05×	17.38×	22.29×	17.43×	11.56×	4.08×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	12.9%	3.0%	3.9%	3.2%	4.1%	7.7%	8.1%	3.5%
Return on invested capital	1.2%	1.8%	1.8%	2.9%	3.5%	4.5%	7.3%	3.5%
Return on assets	6.5%	1.1%	1.5%	1.8%	3.7%	3.7%	2.8%	2.0%
Free cash flow yield	-1.9%	-2.9%	2.2%	-0.2%	-0.3%	0.5%	5.6%	-1.4%
Earnings yield	6.6%	0.8%	0.6%	0.8%	0.7%	1.2%	9.9%	4.2%
Enterprise value	₹417.1M	₹701.1M	₹1.1B	₹678.6M	₹941.4M	₹1.1B	₹131.4M	₹128.9M
Net debt / EBITDA	-0.08×	0.29×	-1.41×	0.38×	0.22×	-0×	0.47×	1.33×
Cash conversion cycle (days)	186	96	58	97	130	58	43	55